Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00484107

Enrollment

200

Registered

2007-06-08

Start date

2005-09-30

Completion date

2006-10-31

Last updated

2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopause

Brief summary

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

Interventions

DRUGConjugated Estrogen Cream (Premarin®)

Eligibility

Sex/Gender

FEMALE

Age

40 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients in whom Premarin vaginal cream is indicated. * In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study. * Provide signed informed consent.

Exclusion criteria

* Patients not willing to give informed consent.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026